Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/cd/7b/ef/cd7bef13-2f6c-ec7c-5332-0d014ca9308b/mza_2534052509331663784.jpg/600x600bb.jpg
MedtronicTalks
Tom Salemi
47 episodes
2 months ago
In this episode of MedtronicTalks, Que Dallara, EVP and President of the Diabetes Business at Medtronic, discusses the company's recent advancements in diabetes management. Dallara, transitioning from the software and technology industry to the medical device industry, draws parallels between control systems in different fields and their application to diabetes management, particularly in the development of closed-loop algorithms for insulin dosing. She also highlights the FDA-approved MiniMed 780G system, which simplifies diabetes management with automatic adjustments for insulin dosing and carbohydrate counting. Finally, Dallara addresses Medtronic's ongoing engagement with the FDA and news of the launch of the MiniMed 780G system in the U.S., sharing more about its meal detection technology and benefits. Thank you to GlobalMed-MDI for sponsoring this episode. To learn more about how GlobalMed-MDI works with medical device companies, visit www.moldeddevices.com. Thank you for listening to the Medtronic Podcast. Subscribe to this podcast on every major podcast platform.
Show more...
Technology
RSS
All content for MedtronicTalks is the property of Tom Salemi and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of MedtronicTalks, Que Dallara, EVP and President of the Diabetes Business at Medtronic, discusses the company's recent advancements in diabetes management. Dallara, transitioning from the software and technology industry to the medical device industry, draws parallels between control systems in different fields and their application to diabetes management, particularly in the development of closed-loop algorithms for insulin dosing. She also highlights the FDA-approved MiniMed 780G system, which simplifies diabetes management with automatic adjustments for insulin dosing and carbohydrate counting. Finally, Dallara addresses Medtronic's ongoing engagement with the FDA and news of the launch of the MiniMed 780G system in the U.S., sharing more about its meal detection technology and benefits. Thank you to GlobalMed-MDI for sponsoring this episode. To learn more about how GlobalMed-MDI works with medical device companies, visit www.moldeddevices.com. Thank you for listening to the Medtronic Podcast. Subscribe to this podcast on every major podcast platform.
Show more...
Technology
https://i1.sndcdn.com/artworks-p5Pz54iAOmVNCT6f-HhyBTw-t3000x3000.jpg
Medtronic’s Hess shares how the DRM program helps bring safer, better devices to market more quickly
MedtronicTalks
25 minutes 49 seconds
3 years ago
Medtronic’s Hess shares how the DRM program helps bring safer, better devices to market more quickly
In this episode of the MedtronicTalks Podcast, Mike Hess, vice president of corporate technology and innovation at Medtronic, will introduce listeners to Design for Reliability & Manufacturability, a design framework that equips engineers, designers and others with a set of standards that ensure new devices are designed right from the start. The DRM program has taken on increased importance as Medtronic moved into a new corporate structure with 20 individual business units. In this discussion, Hess will explain how the DRM program instills uniformity across the world’s largest medical device company. This episode is sponsored by Performance Motion Devices.
MedtronicTalks
In this episode of MedtronicTalks, Que Dallara, EVP and President of the Diabetes Business at Medtronic, discusses the company's recent advancements in diabetes management. Dallara, transitioning from the software and technology industry to the medical device industry, draws parallels between control systems in different fields and their application to diabetes management, particularly in the development of closed-loop algorithms for insulin dosing. She also highlights the FDA-approved MiniMed 780G system, which simplifies diabetes management with automatic adjustments for insulin dosing and carbohydrate counting. Finally, Dallara addresses Medtronic's ongoing engagement with the FDA and news of the launch of the MiniMed 780G system in the U.S., sharing more about its meal detection technology and benefits. Thank you to GlobalMed-MDI for sponsoring this episode. To learn more about how GlobalMed-MDI works with medical device companies, visit www.moldeddevices.com. Thank you for listening to the Medtronic Podcast. Subscribe to this podcast on every major podcast platform.